SEPHguarding acute myeloid leukemia

Malini Gupta, Britta Will

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations


Adaptive aberrant gene regulation is a hallmark of malignant growth and therapy resistance in acute myeloid leukemia (AML). In this issue of Cell Stem Cell, Eagle et al. identified oncogenic enhancer-driven overexpression of selenophosphate synthetase 2 (SEPHS2) as an opportunity for targeted mitigation of malignant cell growth in AML.

Original languageEnglish (US)
Pages (from-to)350-352
Number of pages3
JournalCell Stem Cell
Issue number3
StatePublished - Mar 3 2022

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology


Dive into the research topics of 'SEPHguarding acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this